Cargando…
The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study
Chronic airflow limitation (CAL) can be defined as fixed ratio of forced expiratory volume in 1 s (FEV(1))/forced vital capacity (FVC) < 0.70 after bronchodilation. It is unclear which is the most optimal ratio in relation to respiratory morbidity. The aim was to investigate to what extent differ...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898324/ https://www.ncbi.nlm.nih.gov/pubmed/33284499 http://dx.doi.org/10.1111/cpf.12684 |
_version_ | 1783653840077193216 |
---|---|
author | Torén, Kjell Schiöler, Linus Lindberg, Anne Andersson, Anders Behndig, Annelie F. Bergström, Göran Blomberg, Anders Caidahl, Kenneth Engvall, Jan E. Eriksson, Maria J. Hamrefors, Viktor Janson, Christer Kylhammar, David Lindberg, Eva Lindén, Anders Malinovschi, Andrei Lennart Persson, Hans Sandelin, Martin Eriksson Ström, Jonas Tanash, Hanan Vikgren, Jenny Johan Östgren, Carl Wollmer, Per Sköld, C. Magnus |
author_facet | Torén, Kjell Schiöler, Linus Lindberg, Anne Andersson, Anders Behndig, Annelie F. Bergström, Göran Blomberg, Anders Caidahl, Kenneth Engvall, Jan E. Eriksson, Maria J. Hamrefors, Viktor Janson, Christer Kylhammar, David Lindberg, Eva Lindén, Anders Malinovschi, Andrei Lennart Persson, Hans Sandelin, Martin Eriksson Ström, Jonas Tanash, Hanan Vikgren, Jenny Johan Östgren, Carl Wollmer, Per Sköld, C. Magnus |
author_sort | Torén, Kjell |
collection | PubMed |
description | Chronic airflow limitation (CAL) can be defined as fixed ratio of forced expiratory volume in 1 s (FEV(1))/forced vital capacity (FVC) < 0.70 after bronchodilation. It is unclear which is the most optimal ratio in relation to respiratory morbidity. The aim was to investigate to what extent different ratios of FEV(1)/FVC were associated with any respiratory symptom. In a cross‐sectional general population study, 15,128 adults (50–64 years of age), 7,120 never‐smokers and 8,008 ever‐smokers completed a respiratory questionnaire and performed FEV(1) and FVC after bronchodilation. We calculated different ratios of FEV(1)/FVC from 0.40 to 1.0 using 0.70 as reference category. We analysed odds ratios (OR) between different ratios and any respiratory symptom using adjusted multivariable logistic regression. Among all subjects, regardless of smoking habits, the lowest odds for any respiratory symptom was at FEV(1)/FVC = 0.82, OR 0.48 (95% CI 0.41–0.56). Among never‐smokers, the lowest odds for any respiratory symptom was at FEV(1)/FVC = 0.81, OR 0.53 (95% CI 0.41–0.70). Among ever‐smokers, the odds for any respiratory symptom was lowest at FEV(1)/FVC = 0.81, OR 0.43 (95% CI 0.16–1.19), although the rate of inclining in odds was small in the upper part, that is FEV(1)/FVC = 0.85 showed similar odds, OR 0.45 (95% CI 0.38–0.55). We concluded that the odds for any respiratory symptoms continuously decreased with higher FEV(1)/FVC ratios and reached a minimum around 0.80–0.85, with similar results among never‐smokers. These results indicate that the optimal threshold associated with respiratory symptoms may be higher than 0.70 and this should be further investigated in prospective longitudinal studies. |
format | Online Article Text |
id | pubmed-7898324 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78983242021-03-03 The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study Torén, Kjell Schiöler, Linus Lindberg, Anne Andersson, Anders Behndig, Annelie F. Bergström, Göran Blomberg, Anders Caidahl, Kenneth Engvall, Jan E. Eriksson, Maria J. Hamrefors, Viktor Janson, Christer Kylhammar, David Lindberg, Eva Lindén, Anders Malinovschi, Andrei Lennart Persson, Hans Sandelin, Martin Eriksson Ström, Jonas Tanash, Hanan Vikgren, Jenny Johan Östgren, Carl Wollmer, Per Sköld, C. Magnus Clin Physiol Funct Imaging Original Articles Chronic airflow limitation (CAL) can be defined as fixed ratio of forced expiratory volume in 1 s (FEV(1))/forced vital capacity (FVC) < 0.70 after bronchodilation. It is unclear which is the most optimal ratio in relation to respiratory morbidity. The aim was to investigate to what extent different ratios of FEV(1)/FVC were associated with any respiratory symptom. In a cross‐sectional general population study, 15,128 adults (50–64 years of age), 7,120 never‐smokers and 8,008 ever‐smokers completed a respiratory questionnaire and performed FEV(1) and FVC after bronchodilation. We calculated different ratios of FEV(1)/FVC from 0.40 to 1.0 using 0.70 as reference category. We analysed odds ratios (OR) between different ratios and any respiratory symptom using adjusted multivariable logistic regression. Among all subjects, regardless of smoking habits, the lowest odds for any respiratory symptom was at FEV(1)/FVC = 0.82, OR 0.48 (95% CI 0.41–0.56). Among never‐smokers, the lowest odds for any respiratory symptom was at FEV(1)/FVC = 0.81, OR 0.53 (95% CI 0.41–0.70). Among ever‐smokers, the odds for any respiratory symptom was lowest at FEV(1)/FVC = 0.81, OR 0.43 (95% CI 0.16–1.19), although the rate of inclining in odds was small in the upper part, that is FEV(1)/FVC = 0.85 showed similar odds, OR 0.45 (95% CI 0.38–0.55). We concluded that the odds for any respiratory symptoms continuously decreased with higher FEV(1)/FVC ratios and reached a minimum around 0.80–0.85, with similar results among never‐smokers. These results indicate that the optimal threshold associated with respiratory symptoms may be higher than 0.70 and this should be further investigated in prospective longitudinal studies. John Wiley and Sons Inc. 2020-12-22 2021-03 /pmc/articles/PMC7898324/ /pubmed/33284499 http://dx.doi.org/10.1111/cpf.12684 Text en © 2020 The Authors. Clinical Physiology and Functional Imaging published by John Wiley & Sons Ltd on behalf of Scandinavian Society of Clinical Physiology and Nuclear Medicine This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Torén, Kjell Schiöler, Linus Lindberg, Anne Andersson, Anders Behndig, Annelie F. Bergström, Göran Blomberg, Anders Caidahl, Kenneth Engvall, Jan E. Eriksson, Maria J. Hamrefors, Viktor Janson, Christer Kylhammar, David Lindberg, Eva Lindén, Anders Malinovschi, Andrei Lennart Persson, Hans Sandelin, Martin Eriksson Ström, Jonas Tanash, Hanan Vikgren, Jenny Johan Östgren, Carl Wollmer, Per Sköld, C. Magnus The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study |
title | The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study |
title_full | The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study |
title_fullStr | The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study |
title_full_unstemmed | The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study |
title_short | The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study |
title_sort | ratio fev(1)/fvc and its association to respiratory symptoms—a swedish general population study |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898324/ https://www.ncbi.nlm.nih.gov/pubmed/33284499 http://dx.doi.org/10.1111/cpf.12684 |
work_keys_str_mv | AT torenkjell theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT schiolerlinus theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT lindberganne theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT anderssonanders theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT behndigannelief theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT bergstromgoran theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT blomberganders theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT caidahlkenneth theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT engvalljane theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT erikssonmariaj theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT hamreforsviktor theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT jansonchrister theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT kylhammardavid theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT lindbergeva theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT lindenanders theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT malinovschiandrei theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT lennartperssonhans theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT sandelinmartin theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT erikssonstromjonas theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT tanashhanan theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT vikgrenjenny theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT johanostgrencarl theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT wollmerper theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT skoldcmagnus theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT torenkjell ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT schiolerlinus ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT lindberganne ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT anderssonanders ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT behndigannelief ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT bergstromgoran ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT blomberganders ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT caidahlkenneth ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT engvalljane ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT erikssonmariaj ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT hamreforsviktor ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT jansonchrister ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT kylhammardavid ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT lindbergeva ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT lindenanders ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT malinovschiandrei ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT lennartperssonhans ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT sandelinmartin ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT erikssonstromjonas ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT tanashhanan ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT vikgrenjenny ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT johanostgrencarl ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT wollmerper ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy AT skoldcmagnus ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy |